- Home
- NNN vs LNTH Comparison
NNN vs LNTH Comparison
Compare NNN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNN | LNTH |
|---|---|---|
| Founded | 1984 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 4.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | NNN | LNTH |
|---|---|---|
| Price | $39.51 | $66.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $43.33 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 02-10-2026 | 11-06-2025 |
| Dividend Yield | ★ 6.15% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.08 | ★ 2.39 |
| Revenue | $906,297,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $6.04 | $0.01 |
| Revenue Next Year | $4.82 | $0.52 |
| P/E Ratio | ★ $18.77 | $27.80 |
| Revenue Growth | ★ 4.53 | 1.95 |
| 52 Week Low | $35.80 | $47.25 |
| 52 Week High | $44.23 | $111.29 |
Technical Indicators
Market Signals| Indicator | NNN | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 42.25 | 65.46 |
| Support Level | $38.90 | $64.13 |
| Resistance Level | $40.99 | $68.84 |
| Average True Range (ATR) | 0.60 | 2.08 |
| MACD | -0.06 | 0.19 |
| Stochastic Oscillator | 29.19 | 75.19 |
Price Performance
Historical ComparisonAbout NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.